LACRIMAL GLAND RADIOSENSITIVITY IN UVEAL MELANOMA PATIENTS

Karin Muller, Peter Nowak, Nicole Naus, C Pan, CA (Cornelis) van Santen, Peter Levendag, GPM (Gre) Luyten

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Abstract

Purpose: To find a dose-volume effect for inhomogeneous irradiated lacrimal glands. Methods and Materials: Between 1999 and 2006, 72 patients (42 men and 30 women) were treated with fractionated stereotactic radiotherapy in a prospective, nonrandomized clinical trial (median follow-up, 32 months). A total dose of 50 Gy was given on 5 consecutive days. The mean of all Schirmer test results obtained >= 6 months after treatment was correlated with the radiation dose delivered to the lacrimal gland. Also, the appearance of dry eye syndrome (DES) was related to the lacrimal gland dose distribution. Results: Of the 72 patients, 17 developed a late Schirmer value <10 mm; 9 patients developed DES. A statistically significant relationship was found between the received median dose in the lacrimal gland vs. reduced tear production (p = 0.000) and vs. the appearance of DES (p = 0.003), respectively. A median dose of 7 Gy/fraction to the lacrimal gland caused a 50% risk of low Schirmer results. A median dose of 10 Gy resulted in a 50% probability of DES. Conclusion: We found a clear dose-volume relationship for irradiated lacrimal glands with regard to reduced tear production and the appearance of DES. (C) 2009 Elsevier Inc.
Original languageUndefined/Unknown
Pages (from-to)497-502
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume74
Issue number2
DOIs
Publication statusPublished - 2009

Research programs

  • EMC MM-03-32-04
  • EMC OR-01-60-01

Cite this